Dividend King

$ABBV and $BMY deliver above-average dividend yields and growth, standing out as rare healthcare sector exceptions for patient income investors navigating patent cliffs through innovation.

$ABT down 22% after disappointing earnings, but strong medical devices and $21B Exact Sciences deal offer recovery potential for income seekers.

Automatic Data Processing ($ADP) has fallen 36% amid AI concerns, but maintains strong dividend history with 51 consecutive annual increases, presenting potential value opportunity.

Costco and Coca-Cola both offer compelling buy-and-hold cases: Costco excels in earnings stability with 90%+ membership renewal rates, while Coca-Cola wins with 50+ years of dividend increases and 2.6% yield.

Five dividend stocks and ETFs offer yields ranging from 2.6% to 10.6%, spanning REITs, energy, pharma, consumer staples, and covered-call strategies for diversified income.

Berkshire Hathaway receives $848M annually from Coca-Cola dividends, achieving a 65% yield on its original $1.3B investment spanning 30+ years.

Becton Dickinson and Medtronic offer attractive dividend yields of 2.4% and 2.9%, trading below $1,000 with growth potential amid sector pessimism.

Three dividend aristocrats—Pentair, Enterprise Products Partners, and T. Rowe Price Group—offer compelling income and growth opportunities with 117 combined years of consecutive dividend increases.

Tennant stock plunged 26% after Q4 earnings missed expectations due to ERP system transition disruptions, causing $30 million in lost sales and 68% earnings decline.

Johnson & Johnson maintains Dividend King status with 63 consecutive years of dividend increases, offering stable income through its diversified healthcare business and AAA credit rating.

P&G maintains 69-year dividend streak with 2.63% yield and strong cash flow coverage, making it attractive for income-focused investors despite recent sales headwinds.

McDonald's achieves Dividend King status with 50th consecutive dividend increase, supported by $120 billion real estate portfolio generating stable rental income and strong Q4 sales growth.

Kimberly-Clark offers 4.7% dividend yield with 54-year consecutive increase track record. Trading at discount valuation compared to peers, making it attractive for income investors.

Coca-Cola extends dividend streak to 64 years with quarterly increase to $0.53/share, leveraging $11.4B free cash flow and 2.48% yield for steady investor income.

Coca-Cola and Lowe's are reliable dividend stocks with 64 and 25+ years of consecutive increases respectively, offering steady income for long-term portfolios despite modest growth potential.

Altria's 56-year dividend streak attracts income investors with 6.3% yield, but tobacco dependence and lagging smoke-free product development pose growth challenges.

AbbVie stock fell despite strong Q4 results and 10% revenue growth. Investors worry about Humira patent expiration, though new drugs Skyrizi and Rinvoq show promise.